Insigneo Advisory Services’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $810K | Buy |
7,305
+837
| +13% | +$92.8K | 0.07% | 220 |
|
2025
Q1 | $725K | Buy |
6,468
+62
| +1% | +$6.95K | 0.07% | 217 |
|
2024
Q4 | $592K | Sell |
6,406
-2,690
| -30% | -$248K | 0.06% | 257 |
|
2024
Q3 | $763K | Buy |
9,096
+266
| +3% | +$22.3K | 0.08% | 217 |
|
2024
Q2 | $661K | Buy |
8,830
+148
| +2% | +$11.1K | 0.07% | 232 |
|
2024
Q1 | $636K | Buy |
8,682
+427
| +5% | +$31.3K | 0.08% | 219 |
|
2023
Q4 | $669K | Buy |
8,255
+2,228
| +37% | +$180K | 0.09% | 197 |
|
2023
Q3 | $452K | Sell |
6,027
-2,207
| -27% | -$165K | 0.09% | 203 |
|
2023
Q2 | $635K | Buy |
8,234
+2,727
| +50% | +$210K | 0.12% | 160 |
|
2023
Q1 | $457K | Buy |
5,507
+1,867
| +51% | +$155K | 0.15% | 148 |
|
2022
Q4 | $312K | Buy |
+3,640
| New | +$312K | 0.12% | 184 |
|